Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Comments

Loading...

Sunshine Biopharma

SBFMWNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$0.2800

0.0416.67%

At close: -

$0.2800

0.000.00%

After Hours: Jan 31, 7:43 AM EDT

Sunshine Biopharma (SBFMW) Forecast

News

Earnings Sunshine Biopharma (SBFMW) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest news for Sunshine Biopharma (NASDAQ:SBFMW) Stock

Sunshine Biopharma Stock (NASDAQ: SBFMW)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Thursday, August 08, 2024

Trading Halt: Halt status updated at 9:00:00 ...
Benzinga Newsdesk

Wednesday, August 07, 2024

Trading Halt: Halted at 7:50:00 p.m. ET - Tra...
Benzinga Newsdesk

Wednesday, April 17, 2024

Trading Halt: Halt status updated at 9:00:00 ...
Benzinga Newsdesk

Tuesday, April 16, 2024

Trading Halt: Halted at 7:50:00 p.m. ET - Tra...
Benzinga Newsdesk

Thursday, October 20, 2022

EXCLUSIVE: Sunshine Biopharma Says 'The addit...
Benzinga Newsdesk
EXCLUSIVE: Sunshine Biopharma Tells Benzinga ...
Benzinga Newsdesk

Monday, August 08, 2022

Sunshine Biopharma Q2 Report Reveals Approximately 1,940% Increase In Cash & Cash Equivalents And 80% Decrease In Net Loss Within 6 Months
Kenneth Adams - Sponsored

Monday, August 01, 2022

Sunshine Biopharma Extends Aid To The University Of Arizona For Anti-Coronavirus Collaborative Research
Kenneth Adams - Sponsored

Tuesday, April 26, 2022

Sunshine Biopharma Reveals Potential Intellectual Property Position In Connection With Ongoing mRNA-As-Therapeutics-Agents Research
Kenneth Adams - Sponsored

Monday, April 25, 2022

Sunshine Biopharma Files Patent Application Covering Recently Announced mRNA Molecules Found To Be Effective At Destroying Multidrug Resistant Cancer Cells
Sunshine Biopharma - Sponsored

Wednesday, April 06, 2022

Sunshine Biopharma Sees Potential Multi-Billion Dollar Global Market Opportunity As Research Findings Reveal Effectiveness Against Multidrug-Resistant Cancer Cells
Kenneth Adams - Sponsored

Monday, March 14, 2022

Sunshine Biopharma, Inc. Announces Pricing of $8 Million Private Placement Priced At-the-Market
Kenneth Adams - Sponsored

Popular Channels

PreMarket Playbook
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved